Business context and reporting period
Ichor Holdings, Ltd. (NASDAQ: ICHR) designs and manufactures gas and chemical fluid-delivery subsystems, precision-machined components and related products, primarily for semiconductor equipment manufacturers. This 10-K covers the 52-week fiscal year ended December 30, 2022; the comparable 2021 fiscal year contained 53 weeks. The figures below are full-year results, not standalone fourth-quarter results.
Financial performance and liquidity
| Metric | FY2022 | FY2021 |
|---|---|---|
| Revenue | $1,280.1 million | $1,096.9 million |
| Gross margin | 16.6% | 16.2% |
| Operating income / margin | $85.8 million / 6.7% | $81.0 million / 7.4% |
| Net income | $72.8 million | $70.9 million |
| Diluted EPS | $2.51 | $2.45 |
| Operating cash flow | $31.5 million | $15.3 million |
| Capital expenditures | $29.4 million | $20.8 million |
- Non-GAAP net income was $104.9 million and non-GAAP diluted EPS was $3.62, compared with $97.7 million and $3.37 in FY2021. These company-defined measures exclude specified items and should be considered alongside GAAP results.
- Cash and cash equivalents were $86.5 million at year-end. Current assets were $513.5 million and current liabilities were $166.3 million.
- Gross debt principal was $302.5 million: $142.5 million on the term loan and $160.0 million on the revolving facility. Debt maturities include $7.5 million in each of 2023–2025 and $280.0 million in 2026. The year-end interest rate was 5.97%; debt is variable-rate.
- Management said cash, available credit facilities and operating cash flow should fund the business and current obligations for at least the next 12 months and beyond.
Material changes versus FY2021
- Revenue rose 16.7%, reflecting strong wafer-fabrication equipment demand and incremental sales from the November 2021 IMG acquisition. International sales increased to 55.3% of revenue from 50.4%.
- Gross margin expanded 40 basis points, supported by factory utilization, operating leverage and IMG, partly offset by higher labor, materials and logistics costs.
- Operating margin declined 70 basis points, to 6.7%, as operating expenses increased 30.7%, including higher IMG-related, employee, professional-fee and legal-settlement costs.
- Interest expense increased 71.4% to $11.1 million, reflecting higher average borrowings and borrowing rates. Net income increased only 2.7% despite revenue growth.
- Operating cash flow improved, but inventory rose $47.5 million and accounts payable fell $50.2 million, contributing to working-capital cash use. Cash increased $11.0 million for the year.
Outlook, risks and unusual items
- No numerical FY2023 guidance is provided in the supplied filing text. Management cites long-term secular semiconductor demand and technology complexity as growth drivers, while noting near-term uncertainty from inflation, higher interest rates, supply-chain and labor challenges, and export controls affecting China.
- Customer concentration is substantial: Lam Research and Applied Materials represented 79% of FY2022 sales. The company has no long-term contracts requiring minimum customer purchases.
- Employment-related legal matters generated $4.1 million of expected settlement loss accruals in 2022, expected to be finalized and paid within 12 months. The company also began a global reduction-in-force program near year-end.
- Inventory was $283.7 million, including a $17.5 million excess-and-obsolete reserve; FY2022 inventory write-down charges were $5.0 million. Inventory valuation was identified as a critical audit matter.
- The Singapore tax holiday, extended through 2026, reduced 2022 tax expense by approximately $11.7 million. The effective tax rate was 3.4%.
- Management concluded internal control over financial reporting was ineffective due to an unremediated IT general-controls material weakness involving user access and program change management. The auditor issued an adverse opinion on internal control, but an unqualified opinion on the financial statements; no financial-statement misstatements were identified. Management expected remediation before the end of FY2023.
- The credit agreement includes leverage and fixed-charge coverage covenants. Other principal risks include semiconductor cyclicality, pricing pressure, supplier dependence, acquisition integration, foreign-exchange exposure and export-licensing constraints. No material litigation was reported apart from ordinary-course matters.
Important facts for investors to verify
- Customer demand, order timing and concentration, especially exposure to Lam Research and Applied Materials.
- Whether inventory levels and reserves remain appropriate if semiconductor equipment demand weakens.
- Debt availability, covenant headroom, variable-rate exposure and the 2026 maturity profile.
- Progress and independent validation of remediation of the IT-controls material weakness.
- Whether export licenses and China-related restrictions affect shipments, customer relationships or revenue.
- The contribution of the Singapore tax holiday and excluded items to reported versus non-GAAP earnings.